These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 9568787)
1. Prostate-specific antigen production in the female breast: association with progesterone. Sauter ER; Babb J; Daly M; Engstrom PF; Ehya H; Malick J; Diamandis E Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):315-20. PubMed ID: 9568787 [TBL] [Abstract][Full Text] [Related]
2. Biomarkers associated with breast cancer are associated with obesity. Sauter ER; Scott S; Hewett J; Kliethermes B; Ruhlen RL; Basarakodu K; de la Torre R Cancer Detect Prev; 2008; 32(2):149-55. PubMed ID: 18639389 [TBL] [Abstract][Full Text] [Related]
3. Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Petrakis NL; Barnes S; King EB; Lowenstein J; Wiencke J; Lee MM; Miike R; Kirk M; Coward L Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):785-94. PubMed ID: 8896889 [TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Sauter ER; Daly M; Linahan K; Ehya H; Engstrom PF; Bonney G; Ross EA; Yu H; Diamandis E Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):967-70. PubMed ID: 8959318 [TBL] [Abstract][Full Text] [Related]
5. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size. Sauter ER; Ehya H; Babb J; Diamandis E; Daly M; Klein-Szanto A; Sigurdson E; Hoffman J; Malick J; Engstrom PF Br J Cancer; 1999 Dec; 81(7):1222-7. PubMed ID: 10584885 [TBL] [Abstract][Full Text] [Related]
6. Leptin expression in breast nipple aspirate fluid (NAF) and serum is influenced by body mass index (BMI) but not by the presence of breast cancer. Sauter ER; Garofalo C; Hewett J; Hewett JE; Morelli C; Surmacz E Horm Metab Res; 2004 May; 36(5):336-40. PubMed ID: 15156414 [TBL] [Abstract][Full Text] [Related]
7. Estrogen and progesterone levels in nipple aspirate fluid of healthy premenopausal women: relationship to steroid precursors and response proteins. Gann PH; Geiger AS; Helenowski IB; Vonesh EF; Chatterton RT Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):39-44. PubMed ID: 16434584 [TBL] [Abstract][Full Text] [Related]
8. Nipple aspirate fluid color is associated with breast cancer. Sauter ER; Winn JN; Dale PS; Wagner-Mann C Cancer Detect Prev; 2006; 30(4):322-8. PubMed ID: 16963197 [TBL] [Abstract][Full Text] [Related]
9. Prospective multicenter trial to determine the feasibility of collection and predictive ability of breast fluid analysis in postmenopausal women receiving SERMs. Sauter ER; Ganz PA; Ehya H; Hewett JE; Schlatter L; Kliethermes B; Daly MB Breast; 2007 Oct; 16(5):489-94. PubMed ID: 17482465 [TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen (PSA) in women. Yu H; Berkel H J La State Med Soc; 1999 Apr; 151(4):209-13. PubMed ID: 10234897 [TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen expression in nipple aspirate fluid is associated with advanced breast cancer. Sauter ER; Klein G; Wagner-Mann C; Diamandis EP Cancer Detect Prev; 2004; 28(1):27-31. PubMed ID: 15041074 [TBL] [Abstract][Full Text] [Related]
12. Variation in estradiol, estradiol precursors, and estrogen-related products in nipple aspirate fluid from normal premenopausal women. Chatterton RT; Geiger AS; Khan SA; Helenowski IB; Jovanovic BD; Gann PH Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):928-35. PubMed ID: 15184248 [TBL] [Abstract][Full Text] [Related]
13. Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer. Higgins SA; Matloff ET; Rimm DL; Dziura J; Haffty BG; King BL Breast Cancer Res; 2005; 7(6):R1017-22. PubMed ID: 16280052 [TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen in nipple aspiration fluid: menstrual cycle variability and correlation with serum prostate-specific antigen. Mitchell G; Sibley PE; Wilson AP; Sauter E; A'Hern R; Eeles RA Tumour Biol; 2002; 23(5):287-97. PubMed ID: 12595745 [TBL] [Abstract][Full Text] [Related]
16. Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population. Tice JA; Miike R; Adduci K; Petrakis NL; King E; Wrensch MR Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):324-8. PubMed ID: 15734953 [TBL] [Abstract][Full Text] [Related]
17. Hormonal predictors of prostate cancer. Sofikerim M; Eskicorapci S; Oruç O; Ozen H Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161 [TBL] [Abstract][Full Text] [Related]
18. Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: a 25-year prospective study. Buehring GC; Letscher A; McGirr KM; Khandhar S; Che LH; Nguyen CT; Hackett AJ Breast Cancer Res Treat; 2006 Jul; 98(1):63-70. PubMed ID: 16685591 [TBL] [Abstract][Full Text] [Related]
19. Association of abnormal nipple aspirate cytology and mammographic pattern and density. Lee MM; Petrakis NL; Wrensch MR; King EB; Miike R; Sickles E Cancer Epidemiol Biomarkers Prev; 1994; 3(1):33-6. PubMed ID: 8118383 [TBL] [Abstract][Full Text] [Related]
20. Identification of a chemoprevention cohort from a population of women at high risk for breast cancer. Fabian CJ; Kamel S; Zalles C; Kimler BF J Cell Biochem Suppl; 1996; 25():112-22. PubMed ID: 9027607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]